财报披露
NLS Pharmaceutics(NLSP)06-07 05:05
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-050412 Act: 34 Size: 2 MB 网页链接
简介:NLS Pharmaceutics Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司,致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。
今开:0.3452 | 昨收:0.19 |
最高:0.3897 | 最低:0.2167 |
涨停价: | 跌停价: |
总市值:10909802 |
NLS Pharmaceutics(NLSP)06-07 05:05
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-050412 Act: 34 Size: 2 MB 网页链接
NLS Pharmaceutics(NLSP)06-26 04:35
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-055763 Act: 34 Size: 1 MB 网页链接
胡基112706-27 21:59
$NLS Pharmaceutics(NLSP)$ AEX-23 and AEX-19, which target OX1R, show promise in modulating the effects of α-synuclein on neurons, offering potential benefits in treating synucleinopathies like PD.
不靠谱!
NLS Pharmaceutics(NLSP)05-28 21:15
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046825 Act: 34 Size: 27 KB 网页链接
NLS Pharmaceutics(NLSP)05-30 18:05
$NLS Pharmaceutics(NLSP)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001213900-24-047585 Act: 33 Size: 262 KB 网页链接
NLS Pharmaceutics(NLSP)07-01 20:15
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-057569 Act: 34 Size: 624 KB 网页链接
NLS Pharmaceutics(NLSP)07-01 20:35
$NLS Pharmaceutics(NLSP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-24-057574 Act: 33 Size: 450 KB 网页链接
NLS Pharmaceutics(NLSP)06-28 04:55
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-056712 Act: 34 Size: 26 KB 网页链接
NLS Pharmaceutics(NLSP)07-15 21:25
$NLS Pharmaceutics(NLSP)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-061184 Act: 33 Size: 12 KB 网页链接
SeekingBiotech07-29 21:38
$NLS Pharmaceutics(NLSP)$ and Kadimastem Ltd have announced a binding term sheet for a merger.
Under the proposed deal, Kadimastem will become a wholly-owned subsidiary of NLS, with Kadimastem shareholders acquiring an 85% interest in NLSP.
Binding TS。CNS小盘,迷你
SeekingBiotech07-29 21:38
$NLS Pharmaceutics(NLSP)$ and Kadimastem Ltd have announced a binding term sheet for a merger.
Under the proposed deal, Kadimastem will become a wholly-owned subsidiary of NLS, with Kadimastem shareholders acquiring an 85% interest in NLSP.
Binding TS。CNS小盘,迷你查看全文
胡基112706-27 21:59
$NLS Pharmaceutics(NLSP)$ AEX-23 and AEX-19, which target OX1R, show promise in modulating the effects of α-synuclein on neurons, offering potential benefits in treating synucleinopathies like PD.
不靠谱!查看全文
鲜克有终72021-12-01 00:40
$NLS Pharmaceutics(NLSP)$ 日拱一卒无有尽,功不唐捐终入海查看全文
鲜克有终72021-11-30 23:38
冷枪手假亦真2021-07-15 21:24
大喜家的投顾观点2021-03-25 17:00
$NLS Pharmaceutics(NLSP)$什么时候开始起飞查看全文
冷枪手假亦真2021-03-12 22:21
冷枪手假亦真2021-03-12 00:52
赚零花r2021-02-23 01:43
奥马哈买家俱乐部2021-01-29 23:21
$NLS Pharmaceutics(NLSP)$ 要破发的节奏啊,近一个月10块以下的新股上市没有不被爆炒的,你会是例外吗?查看全文
$NLS Pharmaceutics(NLSP)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-061184 Act: 33 Size: 12 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-24-057574 Act: 33 Size: 450 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-057569 Act: 34 Size: 624 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-056712 Act: 34 Size: 26 KB 网页链接
$NLS Pharmaceutics(NLSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001948 Act: 33 Size: 1 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-055763 Act: 34 Size: 1 MB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-055442 Act: 34 Size: 36 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-051717 Act: 34 Size: 30 KB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-050412 Act: 34 Size: 2 MB 网页链接
$NLS Pharmaceutics(NLSP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048522 Act: 34 Size: 11 KB 网页链接